Literature DB >> 11018611

Urinary tract erosions after synthetic pubovaginal slings: diagnosis and management strategy.

J Q Clemens1, J O DeLancey, G J Faerber, O L Westney, E J Mcguire.   

Abstract

OBJECTIVES: To review our experience with the diagnosis and management of genitourinary tract erosions after pubovaginal sling placement.
METHODS: Clinic and operative records from the urology and gynecology services at two university hospitals were reviewed, and 14 patients were identified who underwent surgical treatment for a urogenital tract erosion after pubovaginal sling placement. The presenting symptoms, physical findings, diagnostic procedures, surgical treatments, and outcomes were reviewed.
RESULTS: Six vaginal erosions, six urethral and vaginal erosions, and two bladder erosions occurred. All were associated with synthetic sling or suture materials. Common symptoms included vaginal and urethral pain, irritative voiding symptoms, vaginal discharge and/or bleeding, and recurrent urinary tract infections. All vaginal and urethral erosions were detected by physical examination and cystoscopy. Symptoms resolved after removal of the eroded sling component. Of the 12 patients with vaginal or urethral erosions, 7 developed recurrent postoperative stress incontinence.
CONCLUSIONS: Persistent painful or irritative symptoms after pubovaginal sling placement may be due to urogenital tract erosion, especially if synthetic materials were used. Appropriate evaluation and treatment will result in dramatic symptomatic improvement, although recurrent stress incontinence may occur.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018611     DOI: 10.1016/s0090-4295(00)00740-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  32 in total

Review 1.  Nonautologous sling materials.

Authors:  G M Ghoniem; D S Kapoor
Journal:  Curr Urol Rep       Date:  2001-10       Impact factor: 3.092

Review 2.  A review of the tension-free vaginal tape procedure: outcomes, complications, and theories.

Authors:  M M Brophy; J J Klutke; C G Klutke
Journal:  Curr Urol Rep       Date:  2001-10       Impact factor: 3.092

3.  Delayed vaginal and urethral mesh exposure: 10 years after TVT surgery.

Authors:  Siwatchaya Khanuengkitkong; Tsia-Shu Lo; Anil Krishna Dass
Journal:  Int Urogynecol J       Date:  2012-06-27       Impact factor: 2.894

4.  Late urethral erosion of transobturator suburethral mesh (Obtape): a minimally invasive management under local anaesthesia.

Authors:  Tiago Moura Mendonça; David Martinho; José Palma Dos Reis
Journal:  Int Urogynecol J       Date:  2010-08-04       Impact factor: 2.894

5.  The clinical and urodynamic effects of the tension free bladder neck sling procedure.

Authors:  Cheng-Yu Long; Shih-Cheng Hsu; Yu Chang; Yu-Chieh Chen; Juin-Huang Su; Eing-Mei Tsai
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-06-04

6.  Suprapubically assisted operative cystoscopy in the management of intravesical TVT synthetic mesh segments.

Authors:  Peter Rosenblatt; Samantha Pulliam; Renee Edwards; Sarah Hamilton Boyles
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-02-26

Review 7.  Perineal cellulitis and persistent vaginal erosion after transobturator tape (Obtape)--case report and review of the literature.

Authors:  Kanapathippillai Sivanesan; Mohamed Abdel-Fattah; John Tierney
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-26

8.  SIS graft for anterior vaginal wall prolapse repair--a case-controlled study.

Authors:  Charlotte Chaliha; Usman Khalid; Luciana Campagna; G Alessandro Digesu; Bini Ajay; Vik Khullar
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-05-30

9.  Urethral necrosis and proximal urethro-vaginal fistula resulting from tension-free vaginal tape.

Authors:  Andrew L Siegel
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-15

10.  An uncommon case of urethrovaginal fistula resulting from tension-free vaginal tape.

Authors:  Juan Pablo Estevez; Michel Cosson; Malik Boukerrou
Journal:  Int Urogynecol J       Date:  2010-01-06       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.